Method to distinguish between the MMAC1/PTEN gene and its pseudogene in RT-PCR analysis of point mutations.
Liu
J
J
Section of Experimental Laboratory Medicine, University of Texas, M.D. Anderson Cancer Center, Houston 77030-4095, USA.
Kagan
J
J
D004252:DNA Mutational Analysis; D004262:DNA Restriction Enzymes / Q000378:metabolism; D018076:DNA, Complementary / Q000235:genetics / Q000378:metabolism; D015252:Deoxyribonucleases, Type II Site-Specific / Q000378:metabolism; D016147:Genes, Tumor Suppressor / Q000235:genetics*; D006801:Humans; D051059:PTEN Phosphohydrolase; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics*; D017354:Point Mutation; D011544:Pseudogenes / Q000235:genetics*; D012334:RNA, Neoplasm / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured; D025521:Tumor Suppressor Proteins
D018076:DNA, Complementary; D012334:RNA, Neoplasm; D025521:Tumor Suppressor Proteins; D004262:DNA Restriction Enzymes; C048503:ATGCAT-specific type II deoxyribonucleases; D015252:Deoxyribonucleases, Type II Site-Specific; D010744:Phosphoric Monoester Hydrolases; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human